Skip to content

Intensity Modulated Radiotherapy (IMRT)

RADIATION14 trials

Sponsors

M.D. Anderson Cancer Center, Sanofi, UNC Lineberger Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Julie E. Bauman, MD, MPH

Conditions

Bone SarcomaBreast CancerCarcinoma, Squamous CellCarcinoma, Squamous Cell of Head and NeckCervical CancerChordomaEndometrial CancerEsophageal Cancer

Phase 1

Phase 2

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer
CompletedNCT01266512
SanofiLung Neoplasms
Start: 2011-01-31End: 2014-03-31Updated: 2014-07-16
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
CompletedNCT01530997
UNC Lineberger Comprehensive Cancer CenterCarcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms
Start: 2012-02-07End: 2019-11-30Updated: 2024-11-13
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
Active, not recruitingNCT02008656
Memorial Sloan Kettering Cancer CenterRectal Cancer
Start: 2013-11-30End: 2026-11-30Updated: 2025-08-27
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
CompletedNCT02281955
UNC Lineberger Comprehensive Cancer CenterCarcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms
Start: 2014-08-31End: 2024-11-24Updated: 2025-01-07
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
CompletedNCT03077243
UNC Lineberger Comprehensive Cancer CenterCarcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms
Start: 2016-12-31End: 2022-12-14Updated: 2024-05-02
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
Active, not recruitingNCT03224000
M.D. Anderson Cancer CenterMalignant Neoplasms of Lip Oral Cavity and Pharynx, Oropharyngeal Cancer
Start: 2018-01-17End: 2026-12-31Updated: 2025-12-17
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
NCT04275986
Chinese Academy of Medical SciencesEsophageal Squamous Cell Carcinoma
Start: 2020-01-20End: 2024-03-31Target: 56Updated: 2021-07-07

Unknown Phase

Related Papers

1 more papers not shown